Vertex Pharmaceuticals (VRTX)

Add to Watchlists
Create an Alert
65.01 +0.62  +0.96% NASDAQ Apr 17, 11:32AM BATS Real time Currency in USD

Vertex Pharmaceuticals Cash from Financing (TTM):

180.88M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Vertex Pharmaceuticals Cash from Financing (TTM) Chart

Export Data
Save Image

Vertex Pharmaceuticals Historical Cash from Financing (TTM) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 180.88M
Sept. 30, 2013 169.20M
June 30, 2013 164.34M
March 31, 2013 144.54M
Dec. 31, 2012 172.20M
Sept. 30, 2012 -15.61M
June 30, 2012 -3.694M
March 31, 2012 -86.36M
Dec. 31, 2011 -124.24M
Sept. 30, 2011 68.19M
June 30, 2011 446.62M
March 31, 2011 401.06M
Dec. 31, 2010 425.06M
Sept. 30, 2010 954.27M
June 30, 2010 686.37M
March 31, 2010 687.98M
Dec. 31, 2009 999.01M
Sept. 30, 2009 474.06M
June 30, 2009 568.43M
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Financing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More

Get data for
Advertisement

VRTX Cash from Financing (TTM) Benchmarks

Companies
Amgen 2.726B
Biogen Idec -716.53M
Gilead Sciences -2.544B

VRTX Cash from Financing (TTM) Range, Past 5 Years

Minimum -124.24M Dec 2011
Maximum 999.01M Dec 2009
Average 332.23M
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.